GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 25, 2024 |
PDB ID | UniProt ID | Title | Descriptor ▲ |
---|---|---|---|
7EYA | P0DTC2 | Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-804 Fab | |
7FD9 | P41594 | Thermostabilised full length human mGluR5-5M with orthosteric antagonist, LY341495 | |
7JHM | Q9NY97 | Structure of human beta 1,3-N-acetylglucosaminyltransferase 2 with N-acetyl-lactosamine | |
7JHN | Q9NY97 | Structure of human beta 1,3-N-acetylglucosaminyltransferase 2 with UDP and trisaccharide GlcNAc-beta1-3Gal-beta1-4GlcNAc | |
7JKS | 7JKS | Crystal structure of vaccine-elicited broadly neutralizing VRC01-class antibody 2411a in complex with HIV-1 gp120 core | |
7KDG | P0DTC2 | SARS-CoV-2 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS) | |
7KDK | P0DTC2 | SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G) | |
7KE8 | P0DTC2 | SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification) | |
7KFE | A0A510C2V9 | Bundibugyo virus GP (mucin deleted) bound to antibody Fab BDBV-329 | |
7KFE | B8XCN0 | Bundibugyo virus GP (mucin deleted) bound to antibody Fab BDBV-329 | |
7KFE | 7KFE | Bundibugyo virus GP (mucin deleted) bound to antibody Fab BDBV-329 | |
7KK8 | Q6J5N4 | Fluoride channel Fluc-Ec2 mutant S81T with bromide | |
7KK8 | 7KK8 | Fluoride channel Fluc-Ec2 mutant S81T with bromide | |
7KKB | Q6J5N4 | Fluoride channel Fluc-Ec2 mutant S81C with bromide | |
7KKB | 7KKB | Fluoride channel Fluc-Ec2 mutant S81C with bromide | |
7L2D | P0DTC2 | Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
7L2D | 7L2D | Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
7L63 | P22897 | C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with L-fucose-(alpha 1-2)-D-galactose-(beta1-4)-D-glucose | |
7L64 | P22897 | C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Lewis-a | |
7L65 | P22897 | C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Methyl-GlcNAc | |
7L88 | 7L88 | BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-3 from animal Rh.32034 (Wk26 time point) | |
7L89 | 7L89 | BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-4 from animal Rh.32034 (Wk26 time point) | |
7LAE | P05164 | CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH Compound-4 | |
7LFK | Q31093 | MODEL OF MHC CLASS Ib H2-M3 WITH MOUSE ND1 N-TERMINAL HEPTAPEPTIDE, THR MUTANT, REFINED AT 1.60 ANGSTROMS RESOLUTION | |
7LFK | P01887 | MODEL OF MHC CLASS Ib H2-M3 WITH MOUSE ND1 N-TERMINAL HEPTAPEPTIDE, THR MUTANT, REFINED AT 1.60 ANGSTROMS RESOLUTION | |
7LFK | P03888 | MODEL OF MHC CLASS Ib H2-M3 WITH MOUSE ND1 N-TERMINAL HEPTAPEPTIDE, THR MUTANT, REFINED AT 1.60 ANGSTROMS RESOLUTION | |
7LL2 | Q2N0S6 | Cryo-EM structure of BG505 DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody VRC33.01 Fab | |
7LL2 | Q2N0S7 | Cryo-EM structure of BG505 DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody VRC33.01 Fab | |
7LL2 | 7LL2 | Cryo-EM structure of BG505 DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody VRC33.01 Fab | |
7LLK | O55774 | Cryo-EM structure of Q23.17_DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody 179NC75 Fab | |
7LLK | 7LLK | Cryo-EM structure of Q23.17_DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody 179NC75 Fab | |
7LM8 | P0DTC2 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with two cross-neutralizing antibodies CV38-142 and COVA1-16 Fabs isolated from COVID-19 patients | |
7LM8 | 7LM8 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with two cross-neutralizing antibodies CV38-142 and COVA1-16 Fabs isolated from COVID-19 patients | |
7LST | A0A2N0UU23 | Ruminococcus bromii Amy12-D392A with 63-a-D-glucosyl-maltotriosyl-maltotriose | |
7LSU | A0A2N0UU23 | Ruminococcus bromii Amy12-D392A with 63-a-D-glucosyl-maltotriose | |
7LXZ | P0DTC2 | SARS-CoV-2 S/S2M11/S2L28 Global Refinement | |
7LXZ | 7LXZ | SARS-CoV-2 S/S2M11/S2L28 Global Refinement | |
7LY0 | P0DTC2 | SARS-CoV-2 S/S2M11/S2M28 Local Refinement | |
7LY0 | 7LY0 | SARS-CoV-2 S/S2M11/S2M28 Local Refinement | |
7LYP | P0DTC2 | South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation | |
7MBU | S5UH55 | Cryo-EM structure of zebrafish TRPM5 E337A mutant in the presence of 5 mM calcium (high calcium occupancy in the transmembrane domain) | |
7MG6 | P02866 | Concanavalin A bound to a DNA glycoconjugate, Man-AGCT | |
7MGD | P02866 | Concanavalin A bound to a DNA glycoconjugate, T(Man-T)TT | |
7MJS | 7MJS | Single-Particle Cryo-EM Structure of Major Facilitator Superfamily Domain containing 2A in complex with LPC-18:3 | |
7MJS | F1NCD6 | Single-Particle Cryo-EM Structure of Major Facilitator Superfamily Domain containing 2A in complex with LPC-18:3 | |
7MWX | 7MWX | Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2 with tamarin CD81 | |
7MWX | A0A2I6PIY1 | Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2 with tamarin CD81 | |
7MWX | Q9N0J9 | Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2 with tamarin CD81 | |
7AIS | P04058 | Crystal structure of Torpedo Californica acetylcholinesterase in complex with 6-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl)amino]-N-(4-hydroxy-3-methoxybenzyl)hexanamide | |
7ANA | Q8A7A3 | A single sulfatase is required for metabolism of colonic mucin O-glycans and intestinal colonization by a symbiotic human gut bacterium (BT1622-S1_20) |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024